Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer
Clinical trial NCT03150836 · WITHDRAWN
Trial details
- NCT number
- NCT03150836
- Sponsor
- Terence Friedlander, MD
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-01
- Primary completion
- 2021-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.